Knockdown of Long Non-coding RNA CCAT2 Suppresses Growth and Metastasis of Esophageal Squamous Cell Carcinoma by Inhibiting the -catenin/WISP1 Signaling Pathway
Overview
Authors
Affiliations
Objective: Long non-coding RNA (lncRNA) colon cancer-associated transcript 2 (CCAT2) plays oncogenic roles in several cancers, including esophageal squamous cell carcinoma (ESCC). However, the specific mechanism of how CCAT2 influences ESCC tumorigenesis is still unknown.
Methods: Using RT-qPCR, the mRNA expression levels of CCAT2 in 33 paired ESCC and adjacent non-cancer tissues and cell lines were measured. Lentiviral vector sh-CCAT2 was designed and transfected into TE10 cells. CCK-8 and transwell assays were employed to detect the effects of CCAT2 knockdown on cell proliferation and invasion, respectively. RT-qPCR and western blots were used to detect the effects of CCAT2 knockdown.
Results: CCAT2 was overexpressed in ESCC tissues compared with corresponding adjacent tissues. CCAT2 knockdown could suppress cell proliferation and invasion . Furthermore, knockdown of CCAT2 could suppress the mRNA and protein levels of β-catenin and Wnt-induced-secreted-protein-1 (WISP1), as well as the mRNA levels of their downstream targets VEGF-A, MMP2, and ICAM-1. High expression of CCAT2 and WISP1 were associated with poor prognosis of ESCC patients.
Conclusions: In conclusion, a novel CCAT2/β-catenin/WISP1 axis was revealed in ESCC progression and may provide a promising therapeutic target against ESCC. CCAT2 and WISP1 are potential molecular biomarkers for predicting prognosis of ESCC.
Fu C, Lu Z, Shi J, Liu F, Su X Clin Transl Oncol. 2024; 27(2):580-592.
PMID: 39093516 DOI: 10.1007/s12094-024-03639-6.
Matricellular proteins: Potential biomarkers in head and neck cancer.
Wang Y, Liu X, Wang X, Lu J, Tian Y, Liu Q J Cell Commun Signal. 2024; 18(2):e12027.
PMID: 38946720 PMC: 11208127. DOI: 10.1002/ccs3.12027.
An overview of CCN4 (WISP1) role in human diseases.
Singh K, Oladipupo S J Transl Med. 2024; 22(1):601.
PMID: 38937782 PMC: 11212430. DOI: 10.1186/s12967-024-05364-8.
Saikia S, Postwala H, Athilingam V, Anandan A, Padma V, Kalita P Curr Pharm Biotechnol. 2024; 25(15):1915-1938.
PMID: 38310451 DOI: 10.2174/0113892010265004231116092802.
Liang F, Luo Q, Han H, Zhang J, Yang Y, Chen J Acta Biochim Biophys Sin (Shanghai). 2023; 55(3):367-381.
PMID: 36942988 PMC: 10160232. DOI: 10.3724/abbs.2023021.